RT Journal Article
T1 Unexpected papilledema in a young male with Type 1 diabetes.
A1 Paniagua, Juan A
A1 Bahamondes, Rodrigo
A1 Cano-Sánchez, Antonio
A1 Velasco, Francisco
K1 Cerebral venous sinus thrombosis
K1 inherited thrombophilia
K1 low‐molecular weight heparin treatment
K1 papilledema
K1 type 1 diabetes
AB In young patients with T1D, neurological manifestations of cerebral hypertension should suggest the possibility of a cerebral venous sinus thrombosis (CVST). In these patients an inherited prothrombotic risk factor, including factor V Leiden G1691A gene mutation, should be considered during an event of thrombosis. Improving the glycemic control is the first factor that should be controlled in a patient who carries a genetic prothrombotic risk factor. Anticoagulant treatment should be started as son as CVST has been diagnosed. Long-term antithrombotic treatment with tinzaparin 175 IU/kg/day, a low-molecular weight heparin (LMWH), could be reliable and well tolerated, although an indefinite special follow-up, including neurological controls, is advisable even in asymptomatic patients.
SN 2050-0904
YR 2017
FD 2017-07-04
LK https://hdl.handle.net/10668/26641
UL https://hdl.handle.net/10668/26641
LA en
DS RISalud
RD Apr 17, 2025